Anhui Fengyuan Pharmaceutical Co Ltd (000153) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥69.15 Million ≈ $10.12 Million USD) by net assets (CN¥2.13 Billion ≈ $311.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000153 equity financing ratio to measure how much of total assets are equity-financed.
Anhui Fengyuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Anhui Fengyuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000153 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Anhui Fengyuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anhui Fengyuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Taiwan Mask Corp
TW:2338
|
0.116x |
|
Enseval Putra Megatrading Tbk
JK:EPMT
|
0.035x |
|
Lanpec Technologies Ltd
SHG:601798
|
0.028x |
|
Tesco PLC
LSE:TSCO
|
0.152x |
|
GENERALFINANCE SPA
F:VG30
|
-0.212x |
|
China Bicycle Co Holdings Ltd
SHE:000017
|
-0.042x |
|
Plumas Bancorp
NASDAQ:PLBC
|
0.021x |
|
Shanghai Yahong Moulding Co Ltd
SHG:603159
|
0.056x |
Annual Cash Flow Conversion Efficiency for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Anhui Fengyuan Pharmaceutical Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.13 Billion ≈ $311.10 Million |
CN¥119.30 Million ≈ $17.46 Million |
0.056x | -9.06% |
| 2024-12-31 | CN¥2.05 Billion ≈ $299.38 Million |
CN¥126.24 Million ≈ $18.47 Million |
0.062x | -53.53% |
| 2023-12-31 | CN¥1.92 Billion ≈ $280.78 Million |
CN¥254.75 Million ≈ $37.28 Million |
0.133x | -47.05% |
| 2022-12-31 | CN¥1.75 Billion ≈ $256.78 Million |
CN¥439.99 Million ≈ $64.38 Million |
0.251x | +64.19% |
| 2021-12-31 | CN¥1.56 Billion ≈ $227.94 Million |
CN¥237.88 Million ≈ $34.81 Million |
0.153x | -24.47% |
| 2020-12-31 | CN¥1.45 Billion ≈ $211.88 Million |
CN¥292.75 Million ≈ $42.84 Million |
0.202x | +305.23% |
| 2019-12-31 | CN¥1.33 Billion ≈ $194.20 Million |
CN¥66.21 Million ≈ $9.69 Million |
0.050x | -72.41% |
| 2018-12-31 | CN¥1.29 Billion ≈ $189.03 Million |
CN¥233.59 Million ≈ $34.18 Million |
0.181x | +321.21% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.59 Million |
CN¥52.40 Million ≈ $7.67 Million |
0.043x | -36.72% |
| 2016-12-31 | CN¥1.15 Billion ≈ $168.69 Million |
CN¥78.21 Million ≈ $11.44 Million |
0.068x | +76.59% |
| 2015-12-31 | CN¥1.18 Billion ≈ $173.29 Million |
CN¥45.50 Million ≈ $6.66 Million |
0.038x | +319.25% |
| 2014-12-31 | CN¥1.15 Billion ≈ $167.83 Million |
CN¥10.51 Million ≈ $1.54 Million |
0.009x | +113.74% |
| 2013-12-31 | CN¥1.05 Billion ≈ $154.28 Million |
CN¥-70.31 Million ≈ $-10.29 Million |
-0.067x | -213.22% |
| 2012-12-31 | CN¥775.01 Million ≈ $113.41 Million |
CN¥45.65 Million ≈ $6.68 Million |
0.059x | -18.14% |
| 2011-12-31 | CN¥765.24 Million ≈ $111.98 Million |
CN¥55.06 Million ≈ $8.06 Million |
0.072x | -1.45% |
| 2010-12-31 | CN¥753.81 Million ≈ $110.31 Million |
CN¥55.04 Million ≈ $8.05 Million |
0.073x | +52.92% |
| 2009-12-31 | CN¥678.70 Million ≈ $99.31 Million |
CN¥32.41 Million ≈ $4.74 Million |
0.048x | -37.32% |
| 2008-12-31 | CN¥654.09 Million ≈ $95.71 Million |
CN¥49.82 Million ≈ $7.29 Million |
0.076x | -11.93% |
| 2007-12-31 | CN¥638.89 Million ≈ $93.49 Million |
CN¥55.26 Million ≈ $8.09 Million |
0.086x | +47.97% |
| 2006-12-31 | CN¥620.49 Million ≈ $90.80 Million |
CN¥36.27 Million ≈ $5.31 Million |
0.058x | +0.49% |
| 2005-12-31 | CN¥599.59 Million ≈ $87.74 Million |
CN¥34.88 Million ≈ $5.10 Million |
0.058x | +393.43% |
| 2004-12-31 | CN¥591.07 Million ≈ $86.49 Million |
CN¥-11.72 Million ≈ $-1.71 Million |
-0.020x | +0.35% |
| 2003-12-31 | CN¥576.00 Million ≈ $84.29 Million |
CN¥-11.46 Million ≈ $-1.68 Million |
-0.020x | -206.51% |
| 2002-12-31 | CN¥560.87 Million ≈ $82.07 Million |
CN¥10.48 Million ≈ $1.53 Million |
0.019x | -57.51% |
| 2001-12-31 | CN¥536.15 Million ≈ $78.46 Million |
CN¥23.57 Million ≈ $3.45 Million |
0.044x | -9.55% |
| 2000-12-31 | CN¥532.50 Million ≈ $77.92 Million |
CN¥25.88 Million ≈ $3.79 Million |
0.049x | +154.14% |
| 1999-12-31 | CN¥52.98 Million ≈ $7.75 Million |
CN¥1.01 Million ≈ $148.25K |
0.019x | -- |
About Anhui Fengyuan Pharmaceutical Co Ltd
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.